Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Characterization of interferon-γ-treated melanoma tumor cells for use in dendritic cell-based immunotherapy.

Cancer biotherapy & radiopharmaceuticals - 1 Jun 2011

Cornforth Andrew N, Fowler Abner W, Carbonell Denysha J, Fan Eric, Dillman Robert O

Abstract excerpt

Efficient delivery of tumor-associated antigens to professional antigen-presenting cells is important for inducing a response in patients receiving cancer immunotherapy. Interferon-gamma (IFN-γ) is used by the immune system to combat viral and fungal infections by restricting cell proliferation and, in some cases, inducing apoptosis. Using IFN-γ to activate target tumor cells prior to antigen loading of dendritic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Death
Share to Cell Separation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dendritic Cells

Share to Flow Cytometry

Share to Immunotherapy

Share to Interferon-gamma

Share to Major Histocompatibility Complex

Share to Melanoma

Source

Identifiers

PMID: 21711093
DOI: 10.1089/cbr.2011.0959

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Characterization of interferon-γ-treated melanoma tumor cells for use in dendritic cell-based immunotherapy.PMID 21711093Read ↗

Effective induction of melanoma-antigen-specific CD8+ T cells via Vγ9γδT cell expansion by CD56(high+) Interferon-α-induced dendritic cells.Semantic proximity Read ↗

Dendritic cells differentiated in the presence of IFN-{beta} and IL-3 are potent inducers of an antigen-specific CD8+ T cell response.Semantic proximity Read ↗

IFN-alpha in the generation of dendritic cells for cancer immunotherapy.Semantic proximity Read ↗

Characterization of HLA-G Regulation and HLA Expression in Breast Cancer and Malignant Melanoma Cell Lines upon IFN-γ Stimulation and Inhibition of DNA Methylation.Semantic proximity Read ↗

New approaches to the development of adenoviral dendritic cell vaccines in melanoma.Semantic proximity Read ↗

Stimulation of dendritic cells by DAMPs in ALA-PDT treated SCC tumor cells.Semantic proximity Read ↗

Development of Cell Technologies Based on Dendritic Cells for Immunotherapy of Oncological DiseasesSemantic proximity Read ↗

Dendritic cell vaccines in melanoma: from promise to proof?Semantic proximity Read ↗

Review: dendritic cell immunotherapy for melanoma.Semantic proximity Read ↗

Human uveal melanoma cells inhibit the immunostimulatory function of dendritic cells.Semantic proximity Read ↗

Dendritic cell regulation of NK-cell responses involves lymphotoxin-α, IL-12, and TGF-β.Semantic proximity Read ↗

Dendritic cells transduced with gp100 gene by RGD fiber-mutant adenovirus vectors are highly efficacious in generating anti-B16BL6 melanoma immunity in mice.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.